Preparation of a multifunctional verapamil-loaded nano-carrier based on a self-assembling PEGylated prodrug

Colloids and Surfaces. B, Biointerfaces
Dongping ZhaoGuolin Wu

Abstract

In an effort to prove the inherent side effects of doxorubicin (DOX) and potentially revoke the effects of drug resistance exhibited by cancer cells, we have designed a multifunctional DOX-delivery nano-carrier system able to encapsulate the drug resistance reversal agent Verapamil HCl (VRP·HCl). Hydrophilic short-chain polyethylene glycol (i.e., mPEG) was covalently linked to hydrophobic DOX and a benzoic imine linkage was used to form a linear amphiphilic PEGylated prodrug, namely mPEG-b-DOX. In aqueous solution, the amphiphilic PEG-b-DOX is able to self-assemble to form stable nanoparticles with a DOX loading content of approximately 40 wt% and a diameter of ∼ 143 nm. The resulting nanoparticles can simultaneously serve as an anticancer drug conjugate and as a drug carrier system. Here, the hydrophilic VRP could be encapsulated into the nano-carriers via a conventional dialysis method. The loading efficiency in mPEG-b-DOX nano-carrier was determined to be 53.97% and the loading content was found to be 7.71 wt%. The VRP-loaded nano-carriers grew slightly in size, to a diameter of ∼ 177 nm. We found that the release of DOX and VRP was much faster at a lower pH value. The biological activity of the nano-carriers were evaluated ...Continue Reading

References

Apr 28, 2000·International Journal of Clinical Pharmacology and Therapeutics·H SchuldesB G Woodcock
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Aug 10, 2002·Science·Dennis E Discher, Adi Eisenberg
Mar 12, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Nadia PasseriniLorenzo Rodriguez
Jan 18, 2008·Journal of Pharmaceutical Sciences·C Simone Fishburn
Jun 7, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tomás EtrychKarel Ulbrich
Apr 1, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yogesh PatilJayanth Panyam
Jun 10, 2010·Nanomedicine·Xiaowei Dong, Russell J Mumper
Feb 22, 2011·Advanced Drug Delivery Reviews·Rubi MahatoKun Cheng
Dec 23, 2011·Drug Development and Industrial Pharmacy·Ying-Zheng ZhaoMin Lin
Apr 24, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Xiaojuan WangJianbiao Ma
Jun 23, 2012·International Journal of Pharmaceutics·Smita K PawarPradeep R Vavia
Sep 23, 2014·ACS Macro Letters·Angela X GaoJeremiah A Johnson
Feb 17, 2015·Journal of Advanced Research·Hossam M AbdallahAli M El-Halawany
Sep 12, 2015·Journal of Nanoscience and Nanotechnology·Bi WangPing Gong

❮ Previous
Next ❯

Citations

Jul 14, 2016·Chemistry, an Asian Journal·Xiaozhong Qu, Zhenzhong Yang
Aug 6, 2019·Frontiers in Pharmacology·Yanping LiJinhan He
Nov 13, 2019·International Journal of Pharmaceutics·Yao XiongShiyong Song

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis